Researchers in the Bay Area are deploying AI models to calculate biological age and identify chronic disease markers. These tools analyze complex biomarkers to pinpoint where cellular decay occurs. This approach shifts geriatric care toward preventative precision medicine. Practitioners can now target interventions based on algorithmic predictions rather than chronological age alone.